R‐COMP VS R‐CHOP AS FIRST‐LINE THERAPY FOR DIFFUSE LARGE B‐CELL LYMPHOMA IN PATIENTS OLDER THAN 60 YEARS: RESULTS FROM A RANDOMIZED PHASE 2 STUDY FROM THE SPANISH GELTAMO GROUP. (June 2017) - Sancho, J.